MYCN and neuroblastoma: Furthermore, MYCN-amplified NB cell lines resistant to RA treatment are, instead, sensitive to RNAi-mediated silencing of MYCN, suggesting that this novel therapeutic approach may be effective in MYCN-amplified NBs that have complete or partial resistance toward RA [175].